{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:38:54Z","timestamp":1792273134008,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY022097"],"award-info":[{"award-number":["R01 EY022097"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.drudis.2019.03.027","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T22:21:44Z","timestamp":1554330104000},"page":"1654-1659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Targeting drug delivery within the suprachoroidal space"],"prefix":"10.1016","volume":"24","author":[{"given":"Jae Hwan","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jeremy","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Prausnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2019.03.027_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","article-title":"Overcoming ocular drug delivery barriers through the use of physical forces","volume":"126","author":"Huang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2019.03.027_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2017.07.002","article-title":"Drug delivery devices for retinal diseases","volume":"128","author":"Kaji","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2019.03.027_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","article-title":"In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2019.03.027_bib0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2018.03.001","article-title":"The suprachoroidal space as a route of administration to the posterior segment of the eye","volume":"126","author":"Chiang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2019.03.027_bib0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/17425247.2016.1218460","article-title":"Minimally invasive microneedles for ocular drug delivery","volume":"14","author":"Thakur Singh","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.drudis.2019.03.027_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15171\/bi.2016.07","article-title":"Advanced drug delivery and targeting technologies for the ocular diseases","volume":"6","author":"Barar","year":"2016","journal-title":"Bioimpacts"},{"key":"10.1016\/j.drudis.2019.03.027_bib0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.027_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/OPTH.S89784","article-title":"The suprachoroidal space: From potential space to a space with potential","volume":"10","author":"Moisseiev","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.027_bib0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.drudis.2014.10.010","article-title":"The suprachoroidal pathway: A new drug delivery route to the back of the eye","volume":"20","author":"Rai Udo","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2019.03.027_bib0050","unstructured":"Christian, J. et al. iScience Surgical Corp. Composite ophthalmic microcannula. US7207980B2."},{"key":"10.1016\/j.drudis.2019.03.027_bib0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2147\/OPTH.S57217","article-title":"A review of the istent((r)) trabecular micro-bypass stent: Safety and efficacy","volume":"9","author":"Wellik","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.027_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128146","article-title":"Istent as a solo procedure for glaucoma patients: a systematic review and meta-analysis","volume":"10","author":"Malvankar-Mehta","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2019.03.027_bib0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0034-1368214","article-title":"Two-year clinical experience with the cypass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent","volume":"231","author":"Hoh","year":"2014","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"10.1016\/j.drudis.2019.03.027_bib0070","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1089\/jop.2016.0158","article-title":"Targeted drug delivery within the eye through the suprachoroidal space","volume":"32","author":"Patel","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2019.03.027_bib0075","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1167\/iovs.12-9872","article-title":"Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye","volume":"53","author":"Patel","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.027_bib0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11095-010-0271-y","article-title":"Suprachoroidal drug delivery to the back of the eye using hollow microneedles","volume":"28","author":"Patel","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2019.03.027_bib0085","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1167\/iovs.13-11747","article-title":"Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles","volume":"54","author":"Gilger","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.027_bib0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2018.03.001","article-title":"Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle","volume":"277","author":"Jung","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.027_bib0095","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1167\/iovs.17-23758","article-title":"Targeted drug delivery in the suprachoroidal space by swollen hydrogel pushing","volume":"59","author":"Jung","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.027_bib0100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejpb.2015.05.020","article-title":"Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles","volume":"95","author":"Kim","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2019.03.027_bib0105","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/adhm.201300696","article-title":"Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye","volume":"3","author":"Kim","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.drudis.2019.03.027_bib0110","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.1167\/iovs.14-14651","article-title":"Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles","volume":"55","author":"Kim","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.027_bib0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.5.6.14","article-title":"Suprachoroidal corticosteroid administration: a novel route for local treatment of noninfectious uveitis","volume":"5","author":"Goldstein","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.drudis.2019.03.027_bib0120","unstructured":"Suprachoroidal injection of CLS-TA in subjects with macular edema associated with non-infectious uveitis (peachtree). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02595398 [accessed February 19, 2019]."},{"key":"10.1016\/j.drudis.2019.03.027_bib0125","unstructured":"Suprachoroidal injection of CLS-TA in subjects non-infectious uveitis (azalea). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03097315 [accessed February 19, 2019]."},{"key":"10.1016\/j.drudis.2019.03.027_bib0130","unstructured":"Suprachoroidal injection of CLS-TA alone or with aflibercept in subjects with diabetic macular edema (hulk). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02949024 [accessed February 19, 2019]."},{"key":"10.1016\/j.drudis.2019.03.027_bib0135","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/sj.eye.6702029","article-title":"Suprachoroidal silicone oil: recognition and possible mechanisms","volume":"20","author":"Patel","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.drudis.2019.03.027_bib0140","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMct0908432","article-title":"Panretinal photocoagulation for proliferative diabetic retinopathy","volume":"365","author":"Bressler","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2019.03.027_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2011.05.035","article-title":"Panretinal photocoagulation for proliferative diabetic retinopathy: Pattern scan laser versus argon laser","volume":"153","author":"Chappelow","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.027_bib0150","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1172\/JCI71029","article-title":"Recent developments in the treatment of age-related macular degeneration","volume":"124","author":"Holz","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2019.03.027_bib0155","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1167\/iovs.13-13707","article-title":"Drug and gene delivery to the back of the eye: From bench to bedside","volume":"55","author":"Rowe-Rendleman","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.027_bib0160","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd3790","article-title":"Wet AMD market","volume":"11","author":"Syed","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2019.03.027_bib0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","article-title":"Barriers to glaucoma drug delivery","volume":"17","author":"Ghate","year":"2008","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.drudis.2019.03.027_bib0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.bioeng.6.040803.140055","article-title":"Ocular biomechanics and biotransport","volume":"6","author":"Ethier","year":"2004","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.drudis.2019.03.027_bib0175","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-vegf agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.drudis.2019.03.027_bib0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems. A shift to the posterior segment","volume":"13","author":"Del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2019.03.027_bib0185","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2019.03.027_bib0190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2010.07.107","article-title":"Trans-scleral iontophoretic delivery of low molecular weight therapeutics","volume":"147","author":"Gungor","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.027_bib0195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jconrel.2005.09.049","article-title":"Iontophoresis: a non-invasive ocular drug delivery","volume":"110","author":"Eljarrat-Binstock","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.027_bib0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.eurpolymj.2014.11.024","article-title":"Biomedical applications of hydrogels: a review of patents and commercial products","volume":"65","author":"Calo","year":"2015","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.drudis.2019.03.027_bib0205","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer"},{"key":"10.1016\/j.drudis.2019.03.027_bib0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.addr.2012.09.010","article-title":"Hydrogels for biomedical applications","volume":"64","author":"Hoffman","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2019.03.027_bib0215","doi-asserted-by":"crossref","first-page":"H41","DOI":"10.1002\/adma.201003963","article-title":"Hyaluronic acid hydrogels for biomedical applications","volume":"23","author":"Burdick","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drudis.2019.03.027_bib0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","article-title":"Hyaluronan: Its nature, distribution, functions and turnover","volume":"242","author":"Fraser","year":"1997","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.drudis.2019.03.027_bib0225","doi-asserted-by":"crossref","first-page":"42194","DOI":"10.1002\/app.42194","article-title":"Preparation and physical properties of hyaluronic acid-based cryogels","volume":"132","author":"Strom","year":"2015","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.drudis.2019.03.027_bib0230","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.survophthal.2010.09.001","article-title":"Vitreous substitutes: a comprehensive review","volume":"56","author":"Kleinberg","year":"2011","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.027_bib0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00006982-199803000-00007","article-title":"Long-term follow-up of perfluorocarbon liquid in the anterior chamber","volume":"18","author":"Weinberger","year":"1998","journal-title":"Retina"},{"key":"10.1016\/j.drudis.2019.03.027_bib0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2006.05.018","article-title":"Encapsulated ultrasound microbubbles: therapeutic application in drug\/gene delivery","volume":"114","author":"Liu","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.027_bib0245","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1039\/CT9079102001","article-title":"Cxcvi.\u2014emulsions","volume":"91","author":"Pickering","year":"1907","journal-title":"J. Chem. Soc. Trans."},{"key":"10.1016\/j.drudis.2019.03.027_bib0250","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0001-8686(02)00069-6","article-title":"Emulsions stabilised solely by colloidal particles","volume":"100\u2013102","author":"Aveyard","year":"2003","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.drudis.2019.03.027_bib0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-6980(92)90013-J","article-title":"Prostaglandin e2 binding site distribution and subtype classification in the rabbit iris-ciliary body","volume":"44","author":"Csukas","year":"1992","journal-title":"Prostaglandins"},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2019.03.027_bib0260","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","article-title":"Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction","volume":"53","author":"Toris","year":"2008","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.027_bib0265","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev"},{"key":"10.1016\/j.drudis.2019.03.027_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.09.016","article-title":"Vesicular systems in ocular drug delivery: an overview","volume":"269","author":"Kaur","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2019.03.027_bib0275","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.eye.6701515","article-title":"Prospective survey of adverse reactions to topical antiglaucoma medications in a hospital population","volume":"19","author":"Bhatt","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.drudis.2019.03.027_bib0280","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/PPA.S23780","article-title":"Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review","volume":"5","author":"Reardon","year":"2011","journal-title":"Patient Pref. Adher."},{"key":"10.1016\/j.drudis.2019.03.027_bib0285","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2016.02.041","article-title":"Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma","volume":"228","author":"Chiang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.027_bib0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.4.3.14","article-title":"Development of an experimental drug eluting suprachoroidal microstent as glaucoma drainage device","volume":"4","author":"Hovakimyan","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.drudis.2019.03.027_bib0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2015.02.021","article-title":"Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model","volume":"203","author":"Chen","year":"2015","journal-title":"J. Control. Release"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964461830429X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964461830429X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:01:50Z","timestamp":1778601710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964461830429X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S135964461830429X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2019.03.027","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting drug delivery within the suprachoroidal space","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2019.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}